Posted in | News | NanoOptics

Swedish Government Give Green Light to MAX IV Synchrotron Light Facility

In the Swedish government's research bill for 2009-2012, that was presented today by the Minister of Research Lars Leijonborg, the building of MAX IV is seen as urgent, as it will be important for many scientific areas of strategic interest.

- It is very positive news that MAX IV is one of the most important parts in the government's new strategy for research and innovation. We send our warmest congratulations to MAX-lab!, says Colin Carlile, Director for ESS Scandinavia.

- MAX-lab has developed a technology that will be truly world-leading, and make science possible that is not possible today.

- It is also very good news for ESS Scandinavia, since ESS and MAX IV will be two world-leading tools for materials and life scientists. As seen in several places around the world, synchrotron light and neutrons are the perfect pair, making complementary research results possible. Building the MAX IV and the ESS side by side will be highly beneficial for European science.

- This is therefore a confirmation that ESS, if built in Lund in Sweden will offer unique technological and scientific qualities, not matched by the two other sites competing for the ESS, Bilbao in Sthe Basque region of Spain and Debrecen in Hungary.

Synchrotron light, as used in MAX-lab, and neutrons, as will be used in the ESS, are seen as two complementary analyzing techniques for scientists within a large array of disciplines, for example chemistry, structural biology, and physics, with applications within energy and environmental technology, pharmaceuticals, nano technology and materials research.

The government's research bill is the largest funding increase ever for Swedish research, and the largest reform made by this government.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.